BE897227A - Traitement des troubles allergiques - Google Patents

Traitement des troubles allergiques Download PDF

Info

Publication number
BE897227A
BE897227A BE1/10828A BE1010828A BE897227A BE 897227 A BE897227 A BE 897227A BE 1/10828 A BE1/10828 A BE 1/10828A BE 1010828 A BE1010828 A BE 1010828A BE 897227 A BE897227 A BE 897227A
Authority
BE
Belgium
Prior art keywords
treatment
allergic
immunoglobulin
intact
use according
Prior art date
Application number
BE1/10828A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE897227A publication Critical patent/BE897227A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BE1/10828A 1982-07-13 1983-07-06 Traitement des troubles allergiques BE897227A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8220235 1982-07-13

Publications (1)

Publication Number Publication Date
BE897227A true BE897227A (fr) 1984-01-06

Family

ID=10531629

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/10828A BE897227A (fr) 1982-07-13 1983-07-06 Traitement des troubles allergiques

Country Status (4)

Country Link
JP (1) JPS5931716A (it)
BE (1) BE897227A (it)
IT (1) IT1237341B (it)
PH (1) PH20047A (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200353081A1 (en) * 2018-01-05 2020-11-12 Network Immunology Inc. A combination of plasma immunoglobulin and antigen-specific immunoglobulin for the modification of the immune system and the treatment or prevention of allergic diseases

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8406560D0 (en) * 1984-03-13 1984-04-18 Central Lab Of The Blood Donor Organic compounds

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200353081A1 (en) * 2018-01-05 2020-11-12 Network Immunology Inc. A combination of plasma immunoglobulin and antigen-specific immunoglobulin for the modification of the immune system and the treatment or prevention of allergic diseases
EP3735273A4 (en) * 2018-01-05 2021-11-17 Network Immunology Inc. COMBINATION OF PLASMA IMMUNE LOBULIN AND ANTIGEN-SPECIFIC IMMUNE LOBULIN FOR THE MODIFICATION OF THE IMMUNE SYSTEM AND THE TREATMENT OR PREVENTION OF ALLERGIC DISEASES
US12090202B2 (en) 2018-01-05 2024-09-17 Network Immunology Inc. Combination of plasma immunoglobulin and antigen-specific immunoglobulin for the modification of the immune system and the treatment or prevention of allergic diseases

Also Published As

Publication number Publication date
IT8348665A0 (it) 1983-07-12
JPS5931716A (ja) 1984-02-20
IT1237341B (it) 1993-05-31
PH20047A (en) 1986-09-11

Similar Documents

Publication Publication Date Title
Sopori et al. Effect of nicotine on the immune system: possible regulation of immune responses by central and peripheral mechanisms
Nouri-Aria et al. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity
REYNOLDS Immunoglobulin G and its function in the human respiratory tract
Slavin et al. A pathologic study of allergic bronchopulmonary aspergillosis
Pepys The Relationship of Nonspecific and Specific Factors in the Tuberculin Reaction, A Review
Ring et al. Anaphylactoid reactions to infusions of plasma protein and human serum albumin Role of aggregated proteins and of stabilizers added during production
CH635242A5 (fr) Procede de preparation d'antiserums ou anticorps pour usage therapeutique.
US4234569A (en) Production of aldehyde-treated allergen-containing substances
DK175473B1 (da) Antiinflammatorisk faktor, fremgangsmåde til isolation og anvendelse heraf
Sato et al. Immunotherapy in food allergy: towards new strategies
Lange et al. Steroid therapy of systemic lupus erythematosus based on immunologic considerations
BE1011033A6 (fr) Composition pharmaceutique et/ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune ou du cancer.
EP2358391B1 (fr) Utilisation d'un concentre d'immunoglobulines g (igg) appauvri en anticorps anti-a et anti-b pour le traitement de l'ictere neonatal par incompatibilite foetomaternelle dans le systeme abo
Aronson et al. Passive transfer of experimental allergic uveitis
Henz et al. Causes of urticaria
BE897227A (fr) Traitement des troubles allergiques
Rubin et al. Susceptibility to subacute thyroiditis is genetically influenced: familial occurrence in identical twins
JP7754810B2 (ja) 肝臓再生に使用するための血漿画分
Chauhan et al. Hypersensitivity
FR2555755A1 (fr) Procede de dosage des immunoglobulines humaines qui sont specifiques d'antigenes cancereux humains et application de ce procede dans le serodiagnostic de maladies tumorales primitives
Mu et al. Physical exercise promotes white matter repair after ischemic stroke
EP0099775B1 (fr) Application du N-(diéthylaminoéthyl) 2-méthoxy-5-méthylsulfonyl benzamide dans l'inhibition de la tryptophane pyrrolase
Kataria et al. Immune Thrombocytopenia and Cerebral Venous Sinus Thrombosis Following COVID-19 Vaccination: A Case Report
EP1320552B1 (fr) Procede de production d'immunoglobulines anti-thymocytes humains
WO1986005099A1 (fr) Preparations d'immunoglobulines presentant des titres eleves en anticorps bloquants

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SCHWEIZERISCHES ROTES KREUZ

Effective date: 19870731